메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
TTM-36 IHCA Trial 연구자 (울산대학교 의과대학 서울아산병원) 전상범 (울산대학교)
저널정보
대한신경집중치료학회 Journal of Neurocritical Care Journal of Neurocritical Care Vol.9 No.1
발행연도
2016.1
수록면
7 - 15 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background:Targeted temperature management (TTM) has neuroprotective effects in comatose patients despite restoration of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest. However, no TTM trials have been performed for in-hospital cardiac arrest (IHCA). Methods:We aim to enroll 60 comatose adults with ROSC after IHCA. Eligible patients are randomly assigned in a 2:1 ratio to either the intervention group or the control group with stratification according to the electrocardiography rhythm. Core body temperature is maintained at 36 °C for the initial 72 hours (TTM-36) in the intervention group. Fever control using conventional methods is attempted in the control group. The primary efficacy outcome is Cerebral Performance Category (CPC) of 3-5 at 180 days. The secondary efficacy outcomes include CPC of 3-5 at 7 days and 30 days; modified Rankin Scale of 4-6 at 7 days, 30 days, and 180 days; daily measured serum levels of neuron specific enolase for the first 5 days; predefined electroencephalography patterns suggesting poor prognosis; repeated measurements of brain MRI including diffusion-weighted imaging, fluid attenuated inversion recovery, susceptibility-weighted imaging, high resolution T1-weighted imaging, diffusion tensor imaging, and resting state functional MRI at 4 days, 30 days, and 180 days; detailed neuropsychological tests; questionnaire for depression, quality of life, activities of daily living, and neuropsychiatric symptoms; and scales for parkinsonism and ataxia. The safety outcomes include cardiac re-arrest, arrhythmia, pneumonia, septic shock, infection, bleeding, and shivering. Results:We are currently recruiting the study patients. Conclusion:The results of this trial are expected to provide evidence for feasibility, safety, and efficacy of TTM-36 in patients with IHCA.

목차

등록된 정보가 없습니다.

참고문헌 (32)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0